In sensitivity analyses, the findings were robust. An evaluation that included weights obtained beyond your data-collection windows had results that were in keeping with those of the primary analysis , as did an analysis with adjustment for the number of psychotropic medications. Results for adiposity-related outcomes, including cardiovascular risk factors, are given in the Supplementary Appendix. Intervention Participation Table 3Table 3Offered and Attended Periods for the Intervention Group. Shows data on the amounts of group and specific weight-management periods and group exercise periods that were offered to and attended by individuals in the intervention group.Related StoriesApplying a top restaurant model to healthcare communications: an interview with Brandi Robinson, SanofiAddressing quality of life needs in prostate cancer: an interview with Professor Louis DenisWABA demands global action to support women to mix breastfeeding and workDr. Rossi continuing, Agile is the only business advancing contraceptive patches predicated on the well-set up hormone, levonorgestrel, that includes a 25 year basic safety history in the U.S. And internationally. The comfort and compliance of a weekly contraceptive patch are appealing features to both patients and their doctors, especially when based upon hormones with proven basic safety profiles.